Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane redox-active enzymes comprise a variety of integral membrane proteins, notably terminal oxidases (such as cytochrome bd oxidase and cytochrome bo3 oxidase) that participate in aerobic respiration by transferring electrons and reducing molecular oxygen. These oxidases are essential for bacterial energy production and help bacteria adapt to stress conditions, including the presence of toxins like carbon monoxide. In addition, membrane-associated antioxidant enzymes such as SOD and catalase neutralize harmful reactive oxygen species at the cell envelope, thus defending bacteria against oxidative stress. The unique properties of these enzymes, such as their heme composition and resistance/sensitivity to inhibitors like CO, make them attractive targets for antibacterial drug development[1][2][3][4].
Drugs targeting these enzymes typically act via enzyme inhibition by blocking electron transfer or active site, ligand binding (competition at the heme center), and redox disruption.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane and redox-active enzymes.